CN116832103A - 一种舒筋健络油的制备工艺 - Google Patents
一种舒筋健络油的制备工艺 Download PDFInfo
- Publication number
- CN116832103A CN116832103A CN202311060395.XA CN202311060395A CN116832103A CN 116832103 A CN116832103 A CN 116832103A CN 202311060395 A CN202311060395 A CN 202311060395A CN 116832103 A CN116832103 A CN 116832103A
- Authority
- CN
- China
- Prior art keywords
- oil
- raw
- tendon
- relaxing
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000005728 strengthening Methods 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 80
- 239000003921 oil Substances 0.000 claims abstract description 48
- 239000007788 liquid Substances 0.000 claims abstract description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 41
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 36
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 26
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 18
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 18
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 16
- 239000000341 volatile oil Substances 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004140 cleaning Methods 0.000 claims abstract description 14
- 238000002386 leaching Methods 0.000 claims abstract description 14
- 238000002791 soaking Methods 0.000 claims abstract description 14
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 13
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 13
- 238000010828 elution Methods 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000010298 pulverizing process Methods 0.000 claims abstract description 9
- 238000001291 vacuum drying Methods 0.000 claims abstract description 9
- 239000003480 eluent Substances 0.000 claims abstract description 3
- 235000019198 oils Nutrition 0.000 claims description 45
- 238000000605 extraction Methods 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 17
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 16
- 244000131316 Panax pseudoginseng Species 0.000 claims description 16
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 16
- 241001522129 Pinellia Species 0.000 claims description 16
- 229940041616 menthol Drugs 0.000 claims description 16
- 241000723346 Cinnamomum camphora Species 0.000 claims description 15
- 241000779819 Syncarpia glomulifera Species 0.000 claims description 15
- 229960000846 camphor Drugs 0.000 claims description 15
- 229930008380 camphor Natural products 0.000 claims description 15
- 239000010642 eucalyptus oil Substances 0.000 claims description 15
- 229940044949 eucalyptus oil Drugs 0.000 claims description 15
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 15
- 239000004006 olive oil Substances 0.000 claims description 15
- 235000008390 olive oil Nutrition 0.000 claims description 15
- 239000001739 pinus spp. Substances 0.000 claims description 15
- 229940036248 turpentine Drugs 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 241000173529 Aconitum napellus Species 0.000 claims description 13
- 241000402754 Erythranthe moschata Species 0.000 claims description 10
- 235000019441 ethanol Nutrition 0.000 claims description 10
- 238000000265 homogenisation Methods 0.000 claims description 10
- 241000220317 Rosa Species 0.000 claims description 9
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 241000489492 Arisaema Species 0.000 claims description 7
- 241001416180 Moschidae Species 0.000 claims description 6
- 239000008159 sesame oil Substances 0.000 claims description 6
- 235000011803 sesame oil Nutrition 0.000 claims description 6
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims description 6
- 229940023019 aconite Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims 8
- 239000012156 elution solvent Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000036407 pain Effects 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 10
- 230000005764 inhibitory process Effects 0.000 abstract description 6
- 230000000202 analgesic effect Effects 0.000 abstract description 4
- 230000007721 medicinal effect Effects 0.000 abstract description 4
- 244000178870 Lavandula angustifolia Species 0.000 abstract description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 abstract description 3
- 229940025250 camphora Drugs 0.000 abstract description 3
- 239000010238 camphora Substances 0.000 abstract description 3
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 2
- 241000180649 Panax notoginseng Species 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract 3
- 239000012467 final product Substances 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 14
- 230000002040 relaxant effect Effects 0.000 description 12
- 210000002435 tendon Anatomy 0.000 description 12
- 210000003462 vein Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000010829 isocratic elution Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/025—Recovery by solvent extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种舒筋健络油的制备工艺,包括以下步骤:将生川乌、生天南星、生附子、生半夏药材,清洗、粉碎,放入纯水中煎煮,分离药液和药材,药材干燥后,置于无水乙醇浸泡后,采用超临界二氧化碳提取,收集药材挥发油;将三七中药材清洗、粉碎,加入乙醇溶液中浸泡,收集浸提液;将浸提液和药液混合进行梯度洗脱,收集洗脱液,真空干燥,粉碎,收集干燥药粉;将药材挥发油与干燥药粉混合,加入松节油,搅拌混合,得到混合料液,加入薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油,真空均质,制得舒筋健络油。采用本发明工艺所制备的舒筋健络油,有效提高药油质量,有效提高其药效,尤其提高了镇痛药效,提高疼痛抑制率。
Description
技术领域
本发明涉及药油领域,特别涉及一种舒筋健络油的制备工艺。
背景技术
舒筋健络油主要成分:三七、薄荷脑、生川乌、桉油、生天南星、薰衣草油、生附子、水杨酸甲酯、生半夏、橄榄油、樟脑、松节油。辅料为玫瑰麝香油等。功能主治:祛风活血、消肿止痛。主治风湿骨痛,多种疼痛及肌肉疼痛等。风湿骨痛往往由风湿性关节炎、强直性脊柱炎、纤维肌痛综合征等引起,其特点是关节、肌肉和骨骼的疼痛、不适和僵硬感。严重影响患者的工作和生活。采用传统的制备工艺,耗费药材多,而且药效发挥欠佳。因此,对舒筋健络油工艺进一步开发具有重大意义。
发明内容
鉴于此,本发明提出一种舒筋健络油的制备工艺,有效提高舒筋健络油的药效以及质量。
本发明的技术方案是这样实现的:
一种舒筋健络油的制备工艺,包括以下步骤:
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,放入纯水中煎煮2~4h,分离药液和药材,药材干燥至含水量≤10%,置于无水乙醇浸泡后,采用超临界二氧化碳提取,萃取温度为48~52℃,萃取压力为14~16MPa,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后加入乙醇溶液中浸泡24~48h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,收集洗脱液;
(3)洗脱液采用真空干燥,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,搅拌混合,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油,真空均质,制得舒筋健络油。
优选地,步骤(1)中,所述生川乌、生天南星、生附子、生半夏中药材与纯水的料液质量体积比(kg/L)为1:7~8;按干重计,所述药材与无水乙醇的料液质量体积比(kg/L)为1:4~6。
优选地,步骤(1)中,所述超临界二氧化碳提取的萃取时间为50~70min,解析压力为5.5~6.5MPa,解析温度为38~42℃,二氧化碳流量为18~22L/h。
优选地,步骤(2)中,所述乙醇溶液的体积浓度为40~60%,所述三七与乙醇溶液的料液比kg/L为1:8~10。
优选地,步骤(2),所述梯度洗脱的溶剂为水-乙醇按照体积比95:5、75:25、50:50、25:75、5:95。
优选地,步骤(3)中,所述低温真空干燥的温度为50~60℃,真空度为0.08~-0.02MPa,干燥时间为48~72h。
优选地,步骤(4)中,所述搅拌的温度为35~40℃,转速450~550r/min,搅拌时间为20~40min。
优选地,步骤(5)中,所述均质的温度为25~35℃,真空度为-0.08~-0.05Mpa,转速45~55r/min,均质时间为20~40min。
优选地,所述药材提取物、薄荷脑、樟脑的比例为440~450μl:280~320mg:60~80mg;所述药材提取物、水杨酸甲酯、松节油、橄榄油、桉油、玫瑰麝香油、薰衣草油的体积比例为440~450:140~160:75~85:75~85:75~85:35~45:35~45。
优选地,按重量份计,三七140~160份、生川乌80~120份、生天南星80~120份、生附子80~120份、生半夏80~120份。
与现有技术相比,本发明的有益效果是:
(1)本发明首先将生川乌、生天南星、生附子、生半夏药材煎煮后采用超临界二氧化碳提取,三七药材乙醇浸提后与生川乌、生天南星、生附子、生半夏煎煮后药液采用AB-8大孔树脂进行梯度洗脱,药材挥发油与干燥药粉混合后加入松节油,再加入薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油真空均质,采用本发明工艺所制备的舒筋健络油,有效提高药油质量,有效提高其药效,尤其提高了镇痛药效,提高疼痛抑制率。
(2)本发明首先将生川乌、生天南星、生附子、生半夏药材煎煮后采用超临界二氧化碳提取,不但有效降低毒性成分含量,而且提高活性成分提取;采用本发明超临界二氧化碳提取特定萃取温度、萃取压力,有效提高对活性成分萃取率,提高了药效;三七药材乙醇浸提后与生川乌、生天南星、生附子、生半夏煎煮后药液采用AB-8大孔树脂进行梯度洗脱,采用本发明梯度洗脱程序,进一步提高活性成分收集,同时分离非活性成分,有效提高活性成分含量,进一步提高药效;药材挥发油与干燥药粉混合后加入松节油,形成包裹,再加入薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油,真空均质,进一步提高药油质量,更利于皮肤对药油的吸收,提高活血化瘀、镇痛之药效。
具体实施方式
为了更好理解本发明技术内容,下面提供具体实施例,对本发明做进一步的说明。
实施例1
舒筋健络油的制备:
1.1药材配比:三七150g、生川乌100g、生天南星100g、生附子100g、生半夏100g。
1.2制备工艺
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,按照料液比(kg/L)为1:8放入纯水中煎煮3h,分离药液和药材;将药材干燥至含水量≤10%,按照料液比(kg/L)为1:5置于无水乙醇浸泡后,采用利用超临界二氧化碳提取,萃取温度为50℃,萃取压力为15MPa,萃取时间为60min,解析压力为6.0MPa,解析温度为40℃,二氧化碳流量为20L/h,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后按照料液比kg/L为1:9加入50%v/v乙醇溶液中浸泡36h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,洗脱比例(v/v)95:5、75:25、50:50、25:75、5:95,收集洗脱液;
(3)洗脱液在温度55℃±5℃、真空度-0.01MPa条件下真空干燥60h,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,以500r/min搅拌30min,搅拌过程保持温度38℃±2℃,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、樟脑、水杨酸甲酯、橄榄油、桉油、薰衣草油、玫瑰麝香油,设定均质温度30℃,真空度为-0.07Mpa,转速500r/min条件下真空均质30min,制得舒筋健络油。
步骤(4)-步骤(5)物料配比:药材提取物445.8μl、松节油80μl、薄荷脑300mg、樟脑70mg、水杨酸甲酯150μl、橄榄油80μl、桉油80μl、玫瑰麝香油40μl、薰衣草油40μl。
实施例2
舒筋健络油的制备:
1.1药材配比:三七150g、生川乌100g、生天南星100g、生附子100g、生半夏100g。
1.2制备工艺
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,按照料液比(kg/L)为1:8放入纯水中煎煮2h,分离药液和药材;将药材干燥至含水量≤10%,按照料液比(kg/L)为1:4置于无水乙醇浸泡后,采用利用超临界二氧化碳提取,萃取温度为50℃,萃取压力为15MPa,萃取时间为60min,解析压力为6.0MPa,解析温度为40℃,二氧化碳流量为20L/h,二氧化碳流量为18~22L/h,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后按照料液比kg/L为1:8加入60%v/v乙醇溶液中浸泡24h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,洗脱比例(v/v)95:5、75:25、50:50、25:75、5:95,收集洗脱液;
(3)洗脱液在温度55℃±5℃、真空度-0.01MPa条件下真空干燥48h,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,以450r/min搅拌40min,搅拌过程保持温度38℃±2℃,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、樟脑、水杨酸甲酯、橄榄油、桉油、薰衣草油、玫瑰麝香油,设定均质温度30℃,真空度为-0.07Mpa,转速500r/min条件下真空均质30min,制得舒筋健络油。
步骤(4)-步骤(5)物料配比:药材提取物445.8μl、松节油80μl、薄荷脑300mg、樟脑70mg、水杨酸甲酯150μl、橄榄油80μl、桉油80μl、玫瑰麝香油40μl、薰衣草油40μl。
实施例3
舒筋健络油的制备:
1.1药材配比:三七150g、生川乌100g、生天南星100g、生附子100g、生半夏100g。
1.2制备工艺
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,按照料液比(kg/L)为1:7~8放入纯水中煎煮4h,分离药液和药材;将药材干燥至含水量≤10%,按照料液比(kg/L)为1:6置于无水乙醇浸泡后,采用利用超临界二氧化碳提取,萃取温度为50℃,萃取压力为15MPa,萃取时间为60min,解析压力为6.0MPa,解析温度为40℃,二氧化碳流量为20L/h,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后按照料液比kg/L为1:10加入40%v/v乙醇溶液中浸泡48h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,洗脱比例(v/v)95:5、75:25、50:50、25:75、5:95,收集洗脱液;
(3)洗脱液在温度55℃±5℃、真空度-0.01MPa条件下真空干燥72h,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,以550r/min搅拌20min,搅拌过程保持温度38℃±2℃,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、樟脑、水杨酸甲酯、橄榄油、桉油、薰衣草油、玫瑰麝香油,设定均质温度30℃,真空度为-0.07Mpa,转速500r/min条件下真空均质30min,制得舒筋健络油。
步骤(4)-步骤(5)物料配比:药材提取物445.8μl、松节油80μl、薄荷脑300mg、樟脑70mg、水杨酸甲酯150μl、橄榄油80μl、桉油80μl、玫瑰麝香油40μl、薰衣草油40μl。
实施例4
舒筋健络油的制备:
1.1药材配比:三七150g、生川乌100g、生天南星100g、生附子100g、生半夏100g。
1.2制备工艺
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,按照料液比(kg/L)为1:8放入纯水中煎煮3h,分离药液和药材;将药材干燥至含水量≤10%,按照料液比(kg/L)为1:5置于无水乙醇浸泡后,采用利用超临界二氧化碳提取,萃取温度为52℃,萃取压力为16MPa,萃取时间为70min,解析压力为6.0MPa,解析温度为40℃,二氧化碳流量为20L/h,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后按照料液比kg/L为1:9加入50%v/v乙醇溶液中浸泡36h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,洗脱比例(v/v)95:5、75:25、50:50、25:75、5:95,收集洗脱液;
(3)洗脱液在温度55℃±5℃、真空度-0.01MPa条件下真空干燥60h,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,以500r/min搅拌30min,搅拌过程保持温度38℃±2℃,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、樟脑、水杨酸甲酯、橄榄油、桉油、薰衣草油、玫瑰麝香油,设定均质温度30℃,真空度为-0.07Mpa,转速500r/min条件下真空均质30min,制得舒筋健络油。
步骤(4)-步骤(5)物料配比:药材提取物445.8μl、松节油80μl、薄荷脑300mg、樟脑70mg、水杨酸甲酯150μl、橄榄油80μl、桉油80μl、玫瑰麝香油40μl、薰衣草油40μl。
对比例1
本对比例与实施例1主要区别在于,在实施例1基础上调整超临界二氧化碳提取的萃取温度为45℃,萃取压力为20MPa。其他操作与实施例1基本一致。
对比例2
本对比例与实施例1主要区别在于,在实施例1基础上梯度洗脱调整为等度洗脱,洗脱溶剂体积比为50:50的水-乙醇。其他操作与实施例1基本一致。
对比例3
本对比例与实施例1主要区别在于,将药材提取物与松节油、薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油直接搅拌混合,以800r/min搅拌60min,未采用真空均质处理。其他操作与实施例1基本一致。
药效试验
采用醋酸致扭体试验来评价镇痛作用
选择SPF级健康ICR小鼠,体重20g±2g。小鼠随机分为10组,每组10只,雌雄各半,包括空白组、模型组、阳性对照组、药物组1-7,其中,药物组1-7对应使用实施例1-4以及对比例1-3所制的舒筋健络油。药物组1-7每天腹部涂抹舒筋健络油(1.0g/kg),阳性对照组涂抹酮洛芬凝胶(10g/kg),连续涂抹6d,末次给药20分钟后,各小鼠(除空白组外)腹腔注射0.6%冰醋酸(0.2mL/20g),计算20分钟内小鼠扭体次数和小鼠疼痛抑制率。
疼痛抑制率计算如下:
疼痛抑制率=(A1-A2)/A1*100%,
A1=模型组小鼠20分钟内扭体次数,A2=样品组小鼠20分钟内扭体次数。
结果如下表1:
表1镇痛药效试验结果
平均扭体次数(20min) | 疼痛抑制率 | |
模型组 | 31.2±2.7 | -- |
阳性对照组 | 8.5±1.0** | 72.8% |
实施例1 | 5.3±0.8** | 83.0% |
实施例2 | 6.8±0.9** | 78.2% |
实施例3 | 6.4±0.9** | 79.5% |
实施例4 | 6.1±0.8** | 80.4% |
对比例1 | 7.8±0.9** | 75.0% |
对比例2 | 8.9±1.0** | 71.5% |
对比例3 | 7.3±0.9** | 76.6% |
与模型对照组比较:*p<0.05,**P<0.01。
由表1知,与模型组相比,阳性对照组以及给药组平均扭体次数显著减少(P<0.05),其中,给药组1-4(实施例1-4)的疼痛抑制率较高,尤其是给药组1(实施例1)的疼痛抑制率最高。
相比实施例1,对比例1-3的效果均有所下降。其中,对比例1没有采用本发明超临界二氧化碳提取特定萃取温度、萃取压力,对活性成分萃取率有所下降,导致其药效有所下降。
对比例2采用等度洗脱,其洗脱效果不如实施例1的梯度洗脱效果,导致活性成分含量下降,进而影响药效。
对比例3将药材提取物与松节油、薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油直接搅拌混合,未采用真空均质处理,效果有所下降。可能是实施例1采用的均质处理,使得更利于对活性成分的吸收,进一步提高了吸收效果。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明。
Claims (10)
1.一种舒筋健络油的制备工艺,其特征在于,包括以下步骤:
(1)将生川乌、生天南星、生附子、生半夏中药材,清洗、粉碎,放入纯水中煎煮2~4h,分离药液和药材,药材干燥至含水量≤10%,置于无水乙醇浸泡后,采用超临界二氧化碳提取,萃取温度为48~52℃,萃取压力为14~16MPa,收集药材挥发油;
(2)将三七中药材清洗、粉碎,粉碎后加入乙醇溶液中浸泡24~48h,收集浸提液;将浸提液和步骤(1)药液混合采用AB-8大孔树脂进行梯度洗脱,洗脱溶剂为水-乙醇,收集洗脱液;
(3)洗脱液采用真空干燥,粉碎,收集干燥药粉;
(4)将步骤(1)药材挥发油与步骤(3)干燥药粉混合,得到药材提取物,加入松节油,搅拌混合,得到混合料液;
(5)在步骤(4)混合料液中加入薄荷脑、水杨酸甲酯、樟脑、橄榄油、桉油、薰衣草油、玫瑰麝香油,真空均质,制得舒筋健络油。
2.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(1)中,所述生川乌、生天南星、生附子、生半夏中药材与纯水的料液质量体积比kg/L为1:7~8;按干重计,所述药材与无水乙醇的料液质量体积比kg/L为1:4~6。
3.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(1)中,所述超临界二氧化碳提取的萃取时间为50~70min,解析压力为5.5~6.5MPa,解析温度为38~42℃,二氧化碳流量为18~22L/h。
4.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(2)中,所述乙醇溶液的体积浓度为40~60%,所述三七与乙醇溶液的料液比kg/L为1:8~10。
5.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(2),所述梯度洗脱的溶剂为水-乙醇按照体积比95:5、75:25、50:50、25:75、5:95。
6.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(3)中,所述低温真空干燥的温度为50~60℃,真空度为0.08~-0.02MPa,干燥时间为48~72h。
7.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(4)中,所述搅拌的温度为35~40℃,转速450~550r/min,搅拌时间为20~40min。
8.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,步骤(5)中,所述均质的温度为25~35℃,真空度为-0.08~-0.05Mpa,转速45~55r/min,均质时间为20~40min。
9.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,所述药材提取物、薄荷脑、樟脑的比例为440~450μl:280~320mg:60~80mg;所述药材提取物、水杨酸甲酯、松节油、橄榄油、桉油、玫瑰麝香油、薰衣草油的体积比例为440~450:140~160:75~85:75~85:75~85:35~45:35~45。
10.根据权利要求1所述的舒筋健络油的制备工艺,其特征在于,按重量份计,三七140~160份、生川乌80~120份、生天南星80~120份、生附子80~120份、生半夏80~120份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311060395.XA CN116832103A (zh) | 2023-08-22 | 2023-08-22 | 一种舒筋健络油的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311060395.XA CN116832103A (zh) | 2023-08-22 | 2023-08-22 | 一种舒筋健络油的制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116832103A true CN116832103A (zh) | 2023-10-03 |
Family
ID=88169267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311060395.XA Pending CN116832103A (zh) | 2023-08-22 | 2023-08-22 | 一种舒筋健络油的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116832103A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223015A (zh) * | 2013-05-03 | 2013-07-31 | 广东伊茗药业有限公司 | 一种治疗肌肉酸痛及皮肤痕痒的药物组合物及其制备方法 |
-
2023
- 2023-08-22 CN CN202311060395.XA patent/CN116832103A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223015A (zh) * | 2013-05-03 | 2013-07-31 | 广东伊茗药业有限公司 | 一种治疗肌肉酸痛及皮肤痕痒的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
徐世义: "三七总皂苷提取工艺研究", 特产研究, no. 03, 30 September 2005 (2005-09-30), pages 9 - 12 * |
范震洪: "舒筋健络油微生物限度检查方法的建立", 中国卫生检验杂志, vol. 19, no. 11, 10 November 2009 (2009-11-10), pages 2577 - 2578 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116832103A (zh) | 一种舒筋健络油的制备工艺 | |
CN102526214B (zh) | 一种治疗血管神经性头痛、偏头痛的中药制剂 | |
CN114377095A (zh) | 一种砂仁-檀香挥发油提取方法、治疗胃炎的胶囊及其制备方法 | |
CN109876127B (zh) | 一种养血当归胶囊及其制备方法 | |
CN113413395A (zh) | 一种含松脂醇二葡萄糖苷的组合物及其制备方法和应用 | |
CN108524576B (zh) | 治疗阳痿的药物组合物、药物及药物的制备方法 | |
CN108143800B (zh) | 一种治疗高血压心力衰竭的中药组合物 | |
CN111643540A (zh) | 一种治疗腰肌劳损的杜仲提取物及其制备方法 | |
CN112294884A (zh) | 一种能快速舒缓皮肤痒感、痛感的植物组合物及其制备方法 | |
CN108495645A (zh) | 外敷消炎消肿中药膏剂 | |
CN112294892A (zh) | 具有缓解痛经作用的发酵型四物汤饮品组合物及制备方法 | |
CN116870076B (zh) | 一种抗炎镇痛中药组合物及其制备方法与应用 | |
CN111265609A (zh) | 一种辅助治疗真性近视的中药组合物及其制备方法 | |
CN105853768B (zh) | 一种治疗类风湿性关节炎的中药组方及其制备方法和应用 | |
CN112826904A (zh) | 一种快速治疗乳腺增生病的药物 | |
CN103830371B (zh) | 一种促进脑部微循环的药物制剂 | |
CN111249363B (zh) | 一种用于治疗类风湿性关节炎的药酒及其制作工艺 | |
CN1403113A (zh) | 一种补肾活血生骨的药物及其制备方法 | |
CN112156135B (zh) | 一种用于治疗肠易激综合症的红花逍遥制剂的制备方法 | |
CN112755137B (zh) | 一种治疗轻中度膝骨关节炎的中药组合物及其应用 | |
CN111084842B (zh) | 治疗肩周炎、颈椎病、腰椎间盘突出、骨性关节炎的外用中药组合物 | |
CN101053624A (zh) | 一种治疗前列腺增生、慢性前列腺炎的中药及其制备工艺 | |
CN110934901A (zh) | 一种含有中药成分且防止足部皴裂的修复膏及制备方法 | |
CN117205270A (zh) | 一种组合物及其制备方法与在制备具有乌发作用的产品中的应用 | |
CN112972512A (zh) | 一种防治痛风的当归粉的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |